CAR-TCR Digital Week
September 14 - 17, 2020 - MA USHanson Wade
info@hansonwade.com
Phone:+1 6174554188
We are now approaching three years since the first CAR-T therapy was approved, triggering an eruption of new companies joining the cell immunotherapy revolution to engineer a cancer-free world. Now with armed constructs, novel targets, and next-generation gene engineering, the field is bursting with new approaches to develop safe, clinically effective and globally accessible therapies. Amid this excitement, it is well known that the current approved therapies have encountered some difficulties, specifically around their pricing and uptake in hospitals due to expensive manufacturing processes. Lots of work needs to be done in this space to reduce the cost of goods and improve turnaround time to decrease the overall price of these therapies, improving their accessibility for patients globally. These challenges, in turn, push the need for ground-breaking work in this space, from discovery through to late-stage manufacture, which is what the CAR-TCR Digital Week promises to showcase this September.